SCHEMBL7181898

SCHEMBL7181898

CCCOC(=O)C(C(=O)c1c(Cl)cccc1Cl)c1ccccc1.O=[PH3]

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
MMP8 P22894 1/20 0.42
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
CYP3A4 P08684 2/20 0.37
CHRM2 P08172 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CHRM4 P08173 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
GPR139 Q6DWJ6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182317 0.93 MMP8 (0.41) ALDH1A1MMP8LMNANPC1RAB9A
SCHEMBL7175573 0.92 TSHR (0.44) ALDH1A1MMP8LMNANPC1RAB9A
SCHEMBL7180608 0.91 TSHR (0.46) ALDH1A1LMNANPC1RAB9ACYP1A2
SCHEMBL7180947 0.91 FABP4 (0.38) ALDH1A1MMP8LMNA
SCHEMBL7183704 0.90 TSHR (0.47) ALDH1A1LMNANPC1RAB9ACYP3A4
SCHEMBL7177756 0.90 TSHR (0.47) ALDH1A1LMNANPC1RAB9ACYP3A4
SCHEMBL7183387 0.90 TSHR (0.47) ALDH1A1LMNANPC1RAB9ACYP3A4
SCHEMBL7181137 0.90 TSHR (0.47) ALDH1A1LMNANPC1RAB9ACYP3A4
SCHEMBL7175563 0.89 MMP8 (0.54) ALDH1A1MMP8NPC1RAB9ASMN1; SMN2
SCHEMBL27485661 0.88 MMP8 (0.41) ALDH1A1MMP8LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885MMP8 4404/4885LMNA 3241/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885MMP8 4586/4885LMNA 3247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.